Quantcast
Skin Cancer Risks Higher For Soldiers Serving Abroad

Skin Cancer Risks Higher For Soldiers Serving Abroad

Wayne Wood, Vanderbilt University Medical Center Soldiers deployed to tropical and sunny climates are coming home with increased risk factors for a threat far from the battlefield: skin cancer. In a retrospective study of about 200 veterans...

Latest Oncology Stories

2014-09-16 08:31:38

WASHINGTON, Sept. 16, 2014 /PRNewswire/ -- The Mesothelioma Victims Center is incredibly passionate about compensation for individuals diagnosed with this asbestos exposure form of cancer, especially if they live in New Jersey, New York, or Pennsylvania, and they offer victims, in these states instant access to the nation's most skilled mesothelioma attorneys, who are also among the leaders in mesothelioma compensation nationwide. If a diagnosed victim of mesothelioma does not want to...

2014-09-16 08:29:16

BOTHELL, Wash. and VANCOUVER, B.C., Sept.16, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that patient enrollment has been completed in the Phase 3 AFFINITY trial. The international, randomized, open-label Phase 3 AFFINITY trial is designed to evaluate the potential of custirsen to improve survival outcomes in approximately 630 men with metastatic castrate-resistant prostate cancer (CRPC). Patients have been randomized to receive second-line...

2014-09-16 04:21:18

WHIPPANY, N.J., Sept. 16, 2014 /PRNewswire/ -- Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational oral androgen receptor inhibitor in clinical development. The study, called ARAMIS, evaluates ODM-201 in men with castration-resistant prostate cancer who have rising Prostate Specific Antigen (PSA) levels and no detectable metastases. The trial is designed to...

2014-09-15 23:11:36

A collaborative study between researchers at the University of Colorado Cancer Center and the National Cancer Institute (NCI) published today in the journal Clinical Cancer Research takes an important step toward answering the question: which altered genes are most to blame for bladder cancer? AURORA, Colo. (PRWEB) September 15, 2014 The story of cancer care seems so simple: find the mutated gene that causes cancer and turn it off or fix it. But rarely does a single gene cause cancer....

2014-09-15 23:08:09

The results of a new Italian study suggest that it can take decades for an asbestos ban to have a major impact on the incidence of malignant pleural mesothelioma. Raleigh, NC (PRWEB) September 15, 2014 Researchers in Italy say the asbestos ban instituted by the country in 1992 has yet to have an observable impact on the number of people developing mesothelioma. Click here to read a new article on the research on the Surviving Mesothelioma website. Scientists with the Local Health...

2014-09-15 20:22:10

Data presented at American Society for Radiology (ASTRO) Annual Meeting in San Francisco SAN FRANCISCO, Sept. 15, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced data from two new studies presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting demonstrate the ability of its Decipher® Prostate Cancer Classifier, a genomic test capable of predicting aggressiveness of prostate cancer, to influence treatment decisions and improve patient outcomes for...

2014-09-15 16:28:14

Register, donate and get involved during Think Pink Week at CIBC branches across Canada TORONTO, Sept. 15, 2014 /CNW/ - CIBC (TSX: CM) (NYSE:CM) - CIBC employees across the country are putting on the pink from September 15 to 19, hosting fundraising events and encouraging people to register for the Canadian Breast Cancer Foundation CIBC Run for the Cure taking place on October 5 in communities across Canada. "We are honoured to once again host Think Pink Week events nationwide...

2014-09-15 16:28:12

Multidisciplinary team composed of six organizations awarded $20,000 for groundbreaking work in mesothelioma and non-small cell lung cancer SYDNEY, Sept. 15, 2014 /PRNewswire/ -- EnGeneIC, Ltd., an emerging biopharmaceutical company focused on revolutionizing the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells, announced that, together with the Asbestos Disease Research Institute (ADRI), it has received the 2014 Cancer Institute New...

2014-09-14 23:00:36

A study led by University of Colorado Cancer Center published today in the journal Nature uses a novel approach to target the activation of a protein that drives some cancers. AURORA, Colo. (PRWEB) September 14, 2014 When active, the protein called Ral can drive tumor growth and metastasis in several human cancers including pancreatic, prostate, lung, colon and bladder. Unfortunately, drugs that block its activity are not available. A study published today in the journal Nature uses a...

2014-09-12 23:05:19

North Texas Indoor Trampoline Park to Help Raise Money During the 2014-2015 School Year Frisco, Texas (PRWEB) September 12, 2014 Leukemia, the most common cancer in children under the age of 20 years old, affects about 4,103 school aged children every year in the US alone. For youth and their families, the diagnosis can be both mentally and financially crushing. In an effort to decrease these hardships and incentivize students to raise money for the cause, Urban Air Trampoline Park is...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.